Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorIRCCS Centro San Giovanni di Dio Fatebenefratelli

About this trial

The goal of this clinical study is to investigate if lifestyle changes can help prevent cognitive decline and reduce depressive symptoms in people between the ages of 50 and 80 with depressive symptoms or a diagnosis of major depression, but without signs of cognitive decline.

The main questions it aims to answer are:

* Does regular physical activity improve mood and memory in people who are depressed or have depressive symptoms? * Does cognitive training help prevent mental difficulties in people at risk of cognitive decline? * Do changes in diet and lifestyle alter the composition of the gut microbiota and immuno-related infiammatory factors?

Researchers will compare three different treatment groups to see which intervention is most effective in improving mental and cognitive health.

The participants:

* Will take part to online sessions on healthy eating based on the Mediterranean diet * Some will do regular exercise, supervised by a personal trainer * Others will do weekly cognitive training in small groups at the hospital * They will provide blood and fecal samples and complete cognitive tests and clinical questionnaires at the beginning, at the end of the treatment (12 weeks), and after 3 months.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged between 50 and 80 years;

Diagnosis of DDM according to DSM-5 or depressive symptoms (PHQ-9 or GDS-15 ≥ 5, the choice of test will be justified by the participant's age);

Ability to provide written informed consent.

Disqualifiers

Active gastrointestinal disorders;

Autoimmune disorders;

Chronic inflammatory disorders;

Diagnosis of dementia; cognitive impairment or mild functional impairment.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Mediterranean Diet

    Behavioral

    Participants will receive only the educational intervention about the Mediterranean diet. The program consists of 4-5 online sessions conducted by a nutritionist.

  • Physical Activity

    Behavioral

    In addition to educational sessions on the Mediterranean diet, there will be 2-3 weekly personalized exercise sessions, followed by a dedicated personal trainer at a partner gym. The treatment will last 12 weeks.

  • Cognitive Training

    Behavioral

    In addition to educational sessions on the Mediterranean diet, there will be one weekly cognitive training session in groups, supervised by qualified staff at the IRCCS FBF. The treatment will last for 12 weeks.

Treatment groups

120 Participants
are divided into 3 treatment groups
Group A: Group 1: Control group (CON)Active comparator 1 intervention
Group B: Group 2: CON + physical activityExperimental treatment 2 interventions
Group C: Group 3: CON + Cognitive trainingExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

MADR Scale for Depression

The Montgomery-Åsberg Depression Rating Scale (MADRS) is a clinician-administered scale designed to assess the severity of depressive symptoms. It consists of 10 items, each rated on a scale from 0 to 6, yielding a total score ranging from 0 to 60. Higher scores indicate greater severity of depression, meaning a worse clinical outcome.

Time frame
Baseline, Week 12, and 3-month follow-up (Week 24)
2

PHQ-9

The Patient Health Questionnaire-9 (PHQ-9) is a self-administered instrument used to assess the severity of depressive symptoms based on DSM criteria. It consists of 9 items, each rated from 0 (not at all) to 3 (nearly every day), resulting in a total score ranging from 0 to 27. Higher scores reflect more severe depressive symptoms, indicating a worse clinical outcome.

Time frame
Baseline, Week 12, and 3-month follow-up (Week 24)
3

GDS-15

The Geriatric Depression Scale - Short Form (GDS-15) is a self-report questionnaire designed to screen for depressive symptoms in older adults. It contains 15 yes/no items, with a total score ranging from 0 to 15. Higher scores indicate more severe depressive symptoms, representing a worse clinical outcome.

Time frame
Baseline, Week 12, and 3-month follow-up (Week 24)
4

WHOQOL-BREF

The World Health Organization Quality of Life - Bref (WHOQOL-BREF) is a self-report questionnaire developed by the WHO to assess quality of life across multiple domains. It contains 26 items rated on a 5-point Likert scale. Higher scores indicate a better quality of life, reflecting a more favorable outcome.

Time frame
Baseline, Week 12, and 3-month follow-up (Week 24)

Secondary outcomes

1

Immunitary-related factors levels

Plasma/serum levels of cytokines

Time frame
Baseline, Week 12, and 3-month follow-up (Week 24)
2

Gut Microbiome Composition

Time frame
Baseline, Week 12, and 3-month follow-up (Week 24)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

IRCCS Centro San Giovanni di Dio Fatebenefratelli

Lead sponsor

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)

Collaborator

University of Milan

Collaborator

China Medical University, China

Collaborator

University College Cork

Collaborator

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Collaborator